Wed Sep 24 02:22:36 SGT 2014  
HEPATITIS
B
    Hepatitis B, Jamaica
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Hepatitis B, Jamaica

Summary

Hepatitis B, Jamaica @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Jamaica - Private and confidential service.

Keywords: Hepatitis B Jamaica, Jamaica Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Jamaica
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial
Mon, 22 Sep 2014 23:45:44 +0100 | Journal of Viral Hepatitis
This study aimed to evaluate the efficacy and safety of TDF compared with adefovir dipivoxil (ADV) in Chinese patients with CHB during 48 weeks of treatment (ClinicalTrial.gov number, NCT01300234). A Phase 3, multicentred, randomized, double‐blind, controlled trial compared the efficacy and safety of TDF with ADV in Chinese patients with CHB. The primary endpoint was the proportion of patients with HBV DNA <400 copies/mL in each treatment group at Week 48, using an unpooled Z‐test for superiority. Secondary endpoints included viral suppression, serologic response, histological improvement, normalization of alanine aminotransferase (ALT) levels and the emergence of resistance mutations. A total of 509 patients, 202 hepatitis B e antigen (HBeAg)‐positive and 307 HBeAg‐negative, w...

Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification
Mon, 22 Sep 2014 00:00:00 +0100 | Hepatology
Conclusion: RB1 mutations can be used as a prognostic molecular biomarker for resectable hepatocellular carcinoma. Further study is required to investigate the potential role of FGF19 amplification in driving hepatocarcinogenesis in patients with liver cirrhosis and to investigate the potential of anti‐FGF19 treatment in these patients. (Hepatology 2014) (Source: Hepatology)

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction
Mon, 22 Sep 2014 00:00:00 +0100 | The Journal of Experimental Medicine
The transcription factor T-bet regulates the production of interferon- and cytotoxic molecules in effector CD8 T cells, and its expression correlates with improved control of chronic viral infections. However, the role of T-bet in infections with differential outcome remains poorly defined. Here, we report that high expression of T-bet in virus-specific CD8 T cells during acute hepatitis B virus (HBV) and hepatitis C virus (HCV) infection was associated with spontaneous resolution, whereas T-bet deficiency was more characteristic of chronic evolving infection. T-bet strongly correlated with interferon- production and proliferation of virus-specific CD8 T cells, and its induction by antigen and IL-2 stimulation partially restored functionality in previously dysfunctional T-bet–deficie...

Targeting the C-type Lectins-Mediated Host-Pathogen Interactions with Dextran.
Fri, 19 Sep 2014 22:25:02 +0100 | J Pharm Pharm Sci
This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.

Association between Vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China
Fri, 19 Sep 2014 00:00:00 +0100 | Journal of Gastroenterology and Hepatology
ConclusionsThe prevalence of vitamin D insufficiency is relatively low in our cohort. Patients infected with genotype B had a higher prevalence of vitamin D insufficiency than genotype C. 25‐hydroxyvitamin D serum level is not associated with viral load or fibrosis stage in chronic hepatitis B patients. (Source: Journal of Gastroenterology and Hepatology)

Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme
Fri, 19 Sep 2014 00:00:00 +0100 | Vox Sanguinis
ConclusionOur lookback study suggests a low (0·2–3·3%) but measurable rate of HBV transmission in Australia associated with donors with OBI and supports published evidence that at least some blood component types from OBI donors, including a proportion undetectable by ID‐NAT can transmit HBV by transfusion. (Source: Vox Sanguinis)

T Cells in Hepatitis Fail to Induce Transcription FactorT Cells in Hepatitis Fail to Induce Transcription Factor
Thu, 18 Sep 2014 13:41:53 +0100 | Medscape Medical News Headlines
Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction, researchers have found - but whether boosting T-bet levels in newly infected patients will help eliminate the virus isn't known. Reuters Health Information (Source: Medscape Medical News Headlines)

Development of Therapeutic Vaccine for Angiotensin II
Thu, 18 Sep 2014 07:43:12 +0100 | Journal of Cardiac Failure
Recent research on vaccination has extended its scope from infectious diseases to chronic diseases, including Alzheimers disease, dyslipidemia and hypertension. The aim of this study was to design DNA vaccines for high blood pressure (BP) and eventually develop human vaccine therapy to treat hypertension. Plasmid vector encoding hepatitis B core (HBc)-angiotensin II (Ang II) fusion protein was injected into spontaneously hypertensive rats (SHR) using needleless injection system. Anti-Ang II antibody was successfully produced in HBc-Ang II group, and antibody titers were sustained for at least 6 months. (Source: Journal of Cardiac Failure)

Hepatitis B and C in pregnancy: a review and recommendations for care
Thu, 18 Sep 2014 00:00:00 +0100 | Journal of Perinatology
Authors: J C Dunkelberg, E M F Berkley, K W Thiel & K K Leslie (Source: Journal of Perinatology)

Galectin‐4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma
Wed, 17 Sep 2014 00:00:00 +0100 | Cancer Science
This article is protected by copyright. All rights reserved. (Source: Cancer Science)